A detailed history of Traphagen Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 1,279 shares of LLY stock, worth $1.03 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,279
Previous 1,265 1.11%
Holding current value
$1.03 Million
Previous $1.15 Million 1.05%
% of portfolio
0.13%
Previous 0.14%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$772.14 - $960.02 $10,809 - $13,440
14 Added 1.11%
1,279 $1.13 Million
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $247,180 - $309,982
-341 Reduced 21.23%
1,265 $1.15 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $951,073 - $1.27 Million
1,606 New
1,606 $1.25 Billion
Q4 2023

Jun 17, 2024

SELL
$525.19 - $619.13 $43,590 - $51,387
-83 Reduced 5.17%
1,523 $888 Million
Q3 2023

Jun 17, 2024

SELL
$434.7 - $599.3 $83,462 - $115,065
-192 Reduced 11.96%
1,414 $759 Million
Q2 2023

Jun 17, 2024

SELL
$350.74 - $468.98 $51,909 - $69,409
-148 Reduced 9.22%
1,458 $684 Million
Q1 2023

Jun 17, 2024

BUY
$310.63 - $364.82 $13,046 - $15,322
42 Added 3.69%
1,181 $405 Million
Q4 2022

Jun 17, 2024

SELL
$321.55 - $374.67 $150,163 - $174,970
-467 Reduced 29.08%
1,139 $417 Million
Q3 2022

Jun 17, 2024

SELL
$296.48 - $337.87 $2.2 Million - $2.51 Million
-7,426 Reduced 92.03%
643 $208 Million
Q2 2022

Jun 17, 2024

BUY
$278.73 - $327.27 $1.8 Million - $2.12 Million
6,463 Added 402.43%
8,069 $691 Million
Q1 2022

Jun 17, 2024

SELL
$234.69 - $291.66 $85,896 - $106,747
-366 Reduced 4.09%
8,575 $708 Million
Q4 2021

Jun 17, 2024

BUY
$224.85 - $279.04 $1.65 Million - $2.05 Million
7,335 Added 456.72%
8,941 $547 Million
Q3 2021

Jun 17, 2024

BUY
$221.6 - $272.71 $39,888 - $49,087
180 Added 2.23%
8,264 $486 Million
Q2 2021

Jun 17, 2024

SELL
$180.55 - $233.54 $16,068 - $20,785
-89 Reduced 1.09%
8,084 $510 Million
Q1 2021

Jun 17, 2024

BUY
$164.32 - $212.72 $1.08 Million - $1.4 Million
6,567 Added 408.9%
8,173 $456 Million
Q4 2020

Jun 17, 2024

BUY
$130.46 - $172.63 $371,028 - $490,959
2,844 Added 52.67%
8,244 $340 Million
Q3 2020

Jun 17, 2024

BUY
$146.22 - $169.13 $554,758 - $641,679
3,794 Added 236.24%
5,400 $243 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Traphagen Investment Advisors LLC Portfolio

Follow Traphagen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.